Overview

Assessment of Long Term Treatment With Testosterone Undecanoate in Males With Hypogonadism

Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the preparation of testosterone undecanoate under conditions which resemble real-life situations.
Phase:
Phase 3
Details
Lead Sponsor:
Bayer
Treatments:
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate